期刊文献+

2002~2007年铜绿假单胞菌对美洛培南的耐药情况分析 被引量:2

下载PDF
导出
摘要 2002~2007年,从本院ICU住院感染患者中共检出致病菌8337株,其中铜绿假单胞菌2151株(占25.80%);2002~2007年各年度铜绿假单胞菌对美洛培南的耐药率分别为11.22%、11.49%、12.88%、14.46%、15.85%、17.94%;对美洛培南敏感的铜绿假单胞菌,美洛培南抑制50%受试菌的最低抑菌浓度(MIC50)在2002~2007年各年度分别为(1.26±0.24)、(1.41±0.24)、(1.73±0.29)、(1.94±0.28)、(2.26±0.32)、(2.56±0.35)μg/ml,抑制90%受试菌的最低抑菌浓度(MIC90)分别为(2.41±0.36)、(2.55±0.37)、(2.96±0.32)、(3.25±0.37)、(3.74±0.45)、(4.12±0.48)μg/ml。认为2002~2007年本院ICU感染患者中感染的铜绿假单胞菌对美洛培南的耐药率逐年上升,即使对美洛培南敏感的铜绿假单胞菌,美洛培南的MIC50及MIC90也逐年上升。
出处 《山东医药》 CAS 北大核心 2009年第10期85-86,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1刘永芳,吕晓菊.铜绿假单胞菌对碳青霉烯类抗生素的耐药性[J].中国抗生素杂志,2005,30(11):699-704. 被引量:21
  • 2马越,李景云,张新妹,张力,胡昌勤,金少鸿.2002年临床常见细菌耐药性监测[J].中华检验医学杂志,2004,27(1):38-45. 被引量:460
  • 3Pfaller MA, Jones RN. A review of the in vitro activity of meropene- mand comparative antimicrobial agents tested against 30 254 aerobic and anaerobic pathogens isolated world wide [ J ]. Diagn Microbiol Infect Dis,1997,28(4) :157-163.
  • 4Tsuji T, Nakano H, Matusnmoto H, et al. Laboratory and clinical studies of meropenem in respiratory tract infection [ J ]. Chemotherpy,1992,40( Suppl 1 ) :283-288.
  • 5毛春燕,刘玲丽,符新颖,谷海瀛.1096株铜绿假单胞菌的耐药性分析[J].中国热带医学,2008,8(3):472-473. 被引量:13
  • 6Aloush V, Navon-Venezia S, Seigman-lgra Y ,et al . Multidrug resistant Pseudomonas aeruginosa : risk factors and clinical impact [ J ]. Antimicrob Agents Chemother,2006,50( 1 ) :43-48.

二级参考文献47

  • 1Patzer J, Toleman M A, Deshpande L M, et al. Pseudomonas aeruginosa strains harbouring an unusual blavuM-4gene cassette isolated from hospitalized children in Poland (1998~2001 ) [J]. J Antimicrob Chemother, 2004,53 (3):451.
  • 2Troillet N, Samore M H, Carmeli Y, et al. Imipenemresistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility pattems [J]. Chin Infect Dis, 1997,25:1094.
  • 3Quinn J P, Dudek E J, DiVincenzo C A, et al. Emergence of resistance to imipenem during therapy of Pseudomonas aeruginosa infections [J]. J Infect Dis, 1986,154: 289.
  • 4Pournaras S, Maniati M, Petinaki E, et al. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-[beta]-lactamase gene variants blaVIM-2 and blaVIM-4 [J]. J Antimicrob Chemother , 2003,51(6): 1409.
  • 5Yoneyama H, Nakae T. Mechanism of efficient elimination of protein D2[J]. Antimicrob Agents chemother, 1993,37(11):2385.
  • 6Suzuki Y, Matsumoto Y, Nishinari C, et al. Antimicrobial activities of meropenem against clinically isolated strains in 1997 [J]. Jpn J Antibiot,1999,52(12) :695.
  • 7Tsakris A, Pournaras S, Woodford N, et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece [J]. J Clin Microbiol,2000,38:1290.
  • 8Yan J J, Hsueh P R, Ko W C, et al. Metallo-β-Iactamases in clinical isolates in Taiwan and identification of VIM-3, a novel variant of VIM-2 enzyme [J].Antimicrob Agents Chemother , 2001,45 (8): 2224.
  • 9Pournaras S, Tsakris A, Maniati M, et al. Novel variant (blaVIM-4) of the metallo-[beta]-lactamase gene blavIM-1in a clinical strain of Pseudomonas aeruginosa [J].Antimicrob Agents Chemother , 2002,46: 4026.
  • 10Giske C G, Rylander M, Kronvall G. VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden [J]. Antimicrob Agents Chemother,2003,47 (9): 3034.

共引文献490

同被引文献18

  • 1汪瑞忠,毛美丽,汪海刚,房华,刘艳,孙静凤.上海浦东新区东南地区2004年至2005年细菌耐药情况的分析[J].检验医学,2007,22(2):191-195. 被引量:11
  • 2CLSI.Performance standards for Antimicrobial susceptibility testing; Fifteenth Informational Supplement.CLSI document M100-S17[S].Wayne,PA:Clinical Laboratory Standards Institute,2007.
  • 3Sakoulas G,Moellering RC Jr.Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains[J].Clin Infect Dis,2008,46(5):360-367.
  • 4Appelbaum PC.Microbiology of antibiotic resistance in Staphylococcus aureus[J].Clin Infect Dis,2007,45(Suppl 3):165-170.
  • 5Walsh TR,Bolmstrom A,Qwarstrom A,et al.Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides[J].J Clin Microbiol,2001,39(7):2439-2444.
  • 6Rello J.Acinetobacter baumannii infections in ICU:customization is the key[J].Chest,1999,115(5):1226-1229.
  • 7Castanheira M, Toleman MA, Jones RN, et al. Molecular charac- terization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase [ J ]. Antimicrob Agents Che- mother, 2004,48(12) :4654-4661.
  • 8Nagaa T, Mukae H, Kadota J, et al. Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model[ J]. Anti- microb Agents Chemother, 2004,48(6) :2251-2259.
  • 9Moore NM, Flaws ML. Epidemiology and pathogenesis of Pseudo- monas aeruginosa infections[ J]. Clin Lab Sci, 2011,24 ( 1 ) :43- 46.
  • 10Master RN, Clark RB, Karlowsky JA, et al. Analysis of resist- ance, cross-resistance and antimicrobial combinations for Pseudo- monas aeruginosa isolates from 1997 to 2009[J]. Int J Antimicrob Agents, 2011,38(4) :291-295.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部